Patients Sue Over Severe Side Effects of Weight-Loss Drugs

Patients are suing Novo Nordisk and Eli Lilly, claiming they were not adequately informed about severe side effects of the diabetes drug Ozempic, including stomach paralysis, blood clots, and other health issues. The lawsuits, representing hundreds of patients, argue that the companies downplayed the risks associated with GLP-1 agonists, a class of drugs originally for diabetes but also used for weight loss. The plaintiffs seek to raise awareness about these potential side effects rather than remove the drug from the market.